# FDA UNTITLED_LETTER - Wickliffe Pharmaceutical Inc - September 07, 2023

Source: https://www.globalkeysolutions.net/records/untitled_letter/wickliffe-pharmaceutical-inc/2a133e07-0650-4846-9910-fe6b849886c9

> FDA UNTITLED_LETTER for Wickliffe Pharmaceutical Inc on September 07, 2023. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: UNTITLED_LETTER
- Company Name: Wickliffe Pharmaceutical Inc
- Inspection Date: 2023-09-07
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations I

## Related Documents

- [483 - 2014-05-22](https://www.globalkeysolutions.net/records/483/wickliffe-pharmaceutical-inc/dc5e4f53-ae59-4796-a3bf-5052bac8a61b)
- [WARNING_LETTER - 2014-05-22](https://www.globalkeysolutions.net/records/warning_letter/wickliffe-pharmaceutical-inc/439aaf79-d2ed-4c03-82ce-7e051dfa025b)
- [483 - 2016-04-07](https://www.globalkeysolutions.net/records/483/wickliffe-pharmaceutical-inc/92fe152b-9097-480a-8a59-7ed2f6d5d578)
- [AMENDED_483 - 2023-09-15](https://www.globalkeysolutions.net/records/amended_483/wickliffe-pharmaceutical-inc/5098ba4c-fe5d-4f58-a5b7-8579515da56f)
- [483_RESPONSE - 2023-09-15](https://www.globalkeysolutions.net/records/483_response/wickliffe-pharmaceutical-inc/6e52a9b3-9a08-4849-8d99-5bbb8024469c)

## Related Officers

- [Director of Investigations Branch](https://www.globalkeysolutions.net/people/rebecca-e-dowd/5f0e1a4e-facc-4529-b6c8-2c2ebfcd8b50)
- [Nicholas R. Kirkpatrick](https://www.globalkeysolutions.net/people/nicholas-r-kirkpatrick/97bc668b-11f9-43c4-8e5b-114cea0c2f26)
- [Brian W. Garthwaite](https://www.globalkeysolutions.net/people/brian-w-garthwaite/e852b914-f9b1-41e4-bc64-37e04e1eb27c)

Company: https://www.globalkeysolutions.net/companies/wickliffe-pharmaceutical-inc/86fc3eb8-322a-47f6-8828-f8ccfe8a1f53

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-i/6ded4818-ee3a-46a1-84c1-36de58502b02